IP Library Granted Patent US 11,136,605
Granted Patent B2
US 11,136,605 · App. 16/783,122 · Granted Oct 5, 2021

Production of cannabinoids in modified yeast using a fatty acid feedstock

Inventors: Alexander Hutagalung (San Diego, CA); Jose Miguel Laplaza (San Diego, CA)
Assignee: LEVADURA BIOTECHNOLOGY, INC.
C12P17/06C12N1/16C12P7/42C12Y103/03006C12Y203/01206C12Y404/01026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,136,605
App. No.
16/783,122
Granted
Oct 5, 2021
Kind
B2
Abstract

Strains of yeasts are provided containing the genes for the production of cannabinoids from fatty acids. The enzymes that mediate cannabinoid production are localized to the cytosol, peroxisome or different compartments within the secretory pathway (e.g., endoplasmic reticulum, Golgi, vacuole) to ensure efficient production. The engineered microorganisms produce cannabinoids in a controlled fermentation process.

Claims (21)

1. A method of isolating a polyketide, the method comprising:

providing as a feedstock at least one of a fatty acid, vegetable oil, or an alkane to a genetically modified yeast,

the genetically modified yeast comprising modified enzymes for producing the polyketide in the peroxisome, and

the modified enzymes comprising acyl-CoA oxidase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, beta-ketothiolase, thiolase, acyl-CoA synthase, and Type III polyketide synthase, wherein each modified enzyme comprises a peroxisomal targeting sequence, and wherein each modified enzyme is localized to the peroxisome;

culturing the genetically modified yeast under conditions sufficient to produce in the peroxisome a fatty acid or a fatty acid-CoA that is a substrate for an acyl-CoA synthase or a polyketide synthase, respectively; and

isolating the polyketide from the genetically modified yeast.

2. The method of claim 1 , wherein the acyl-CoA oxidase comprises the protein sequence as set forth in SEQ ID NO: 10.

3. The method of claim 1 , wherein the Type III polyketide synthase is a tetraketide synthase.

4. The method of claim 1 , wherein the Type III polyketide synthase is TKS1 or TKS1p.

5. The method of claim 1 , wherein an olivetolic acid synthase is expressed in the peroxisome.

6. The method of claim 1 , wherein an endogenous acyl-coA oxidase has been replaced with a non-native acyl-coA oxidase.

7. The method of claim 1 , wherein the polyketide is selected from the group consisting of cannabigerolic acid, Δ9-tetrahydrocannabinolic acid, cannabidiolic acid, cannabichromenic acid, cannabigerovarinic acid, tetrahydrocannabivarin acid, cannabidivarinic acid, and cannabichromevarinic acid.

8. The method of claim 1 , wherein the yeast is from a genus selected from the group consisting of Candida, Arxula, Pichia, Scheffersomyces, Kluyveromyces, Saccharomyces, Yarrowia , and Schizosaccharomyces.

9. The method of claim 1 , wherein the yeast is from a genus of Candida.

10. The method of claim 1 , wherein the polyketide is olivetolic acid or hexanoic acid.

11. The method of claim 1 , wherein the peroxisomal targeting sequence has a consensus sequence of [S/A/H/C/E/P/Q/V]-[K/R/H/Q]-[L/F] as set forth in SEQ ID NO: 7.

12. The method of claim 1 , wherein the peroxisomal targeting sequence is GRRAKL as set forth in SEQ ID NO: 6, added to the carboxyl-terminus of the modified enzyme.

13. A method of producing olivetolic acid in a peroxisome, the method comprising:

providing as a feedstock a fatty acid to a genetically modified yeast, the genetically modified yeast comprising modified enzymes comprising acyl-CoA oxidase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, beta-ketothiolase, thiolase, acyl-CoA synthase, and Type III polyketide synthase, wherein each modified enzyme comprises a peroxisomal targeting sequence, and wherein each modified enzyme is localized to the peroxisome for producing the olivetolic acid in the peroxisome;

culturing the microorganism under conditions sufficient to produce in the peroxisome olivetolic acid; and

isolating the olivetolic acid.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2022
From: LEVADURA BIOTECHNOLOGY, INC.
To: PYRONE SYSTEMS, INC.
Reel/Frame 059759/0687 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2021
From: LAPLAZA, JOSE M.; HUTAGALUNG, ALEXANDER
To: LEVADURA BIOTECHNOLOGY, INC.
Reel/Frame 058022/0222 →
RELEASE OF SECURITY INTEREST Recorded Nov 3, 2021
From: KNOBBE, MARTENS, OLSON & BEAR, LLP
To: LEVADURA BIOTECHNOLOGY INC.
Reel/Frame 058008/0618 →
SECURITY INTEREST Recorded Nov 20, 2020
From: LEVADURA BIOTECHNOLOGY INC.
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 054491/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2020
From: LAPLAZA, JOSE M; HUTAGALUNG, ALEXANDER
To: LEVADURA BIOTECHNOLOGY, INC.
Reel/Frame 051849/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2020
From: LAPLAZA, JOSE M.; HUTAGALUNG, ALEXANDER
To: LEVADURA BIOTECHNOLOGY, INC.
Reel/Frame 051850/0373 →
Continuity (4)
Continuation PCTUS2019051357 · Sep 16, 2019
Provisional Application 62731978 · Sep 17, 2018
Provisional Application 62731980 · Sep 17, 2018
Related Publication 20200224231A1 · Jul 16, 2020
Cited By (1)
US 12,442,026